| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hristina Jovanovic, Johan Lundberg, Per Karlsson, Asta Cerin, Tomoyuki Saijo, Andrea Varrone, Christer Halldin, Anna-Lena Nordströ. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. NeuroImage. vol 39. issue 3. 2008-03-25. PMID:18036835. |
sex differences in 5-ht(1a) receptor and 5-htt bp(nd) may reflect biological distinctions in the serotonin system contributing to sex differences in the prevalence of psychiatric disorders such as depression and anxiety. |
2008-03-25 |
2023-08-12 |
human |
| Simona Spinelli, Melanie L Schwandt, Stephen G Lindell, Timothy K Newman, Markus Heilig, Stephen J Suomi, J Dee Higley, David Goldman, Christina S Bar. Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigm. Development and psychopathology. vol 19. issue 4. 2008-03-19. PMID:17931429. |
human studies have suggested an association between a variable length polymorphism in the serotonin transporter gene promoter region and vulnerability to anxiety and depression. |
2008-03-19 |
2023-08-12 |
human |
| John P O'Reardon, Pilar Cristancho, Pramod Pilania, Kiran B Bapatla, Shaokun Chuai, Andrew D Peshe. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depression and anxiety. vol 24. issue 8. 2008-03-13. PMID:17131353. |
this suggests that rtms does not depend on the central availability of serotonin to exert antidepressant effects in major depression. |
2008-03-13 |
2023-08-12 |
human |
| Dulijano Ljubicić, Tamara Stipcević, Nela Pivac, Miro Jakovljević, Dorotea Mück-Sele. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia. Journal of photochemistry and photobiology. B, Biology. vol 89. issue 2-3. 2008-03-13. PMID:17937992. |
the influence of daylight exposure on platelet 5-ht levels in patients with major depression and schizophrenia. |
2008-03-13 |
2023-08-12 |
human |
| Dulijano Ljubicić, Tamara Stipcević, Nela Pivac, Miro Jakovljević, Dorotea Mück-Sele. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia. Journal of photochemistry and photobiology. B, Biology. vol 89. issue 2-3. 2008-03-13. PMID:17937992. |
altered platelet 5-ht concentrations have been associated with psychiatric disorders like depression and schizophrenia. |
2008-03-13 |
2023-08-12 |
human |
| Sh V Vashadz. [Insomnia, serotonin and depression]. Georgian medical news. issue 150. 2008-03-13. PMID:17984558. |
[insomnia, serotonin and depression]. |
2008-03-13 |
2023-08-12 |
human |
| G T Shishkin. [Neuroadaptive changes in brain during selective serotonin reuptake inhibitors action]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. vol 93. issue 11. 2008-03-12. PMID:18198592. |
selective serotonin reuptake inhibitors such as fluoxetine that are widely used for the treatment of depression and anxiety disorders produce neuroadaptive change not only in the serotoninergic system but also in other neuromediator systems. |
2008-03-12 |
2023-08-12 |
Not clear |
| Tatiana Usala, Antonio Clavenna, Alessandro Zuddas, Maurizio Bonat. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 18. issue 1. 2008-03-11. PMID:17662579. |
randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. |
2008-03-11 |
2023-08-12 |
Not clear |
| Manabu Ichikawa, Yuko Okamura-Oho, Kazuro Shimokawa, Shinji Kondo, Sakiko Nakamura, Hideo Yokota, Ryutaro Himeno, Klaus-Peter Lesch, Yoshihide Hayashizak. Expression analysis for inverted effects of serotonin transporter inactivation. Biochemical and biophysical research communications. vol 368. issue 1. 2008-03-10. PMID:18211820. |
inactivation of serotonin transporter (htt) by pharmacologically in the neonate or genetically increases risk for depression in adulthood, whereas pharmacological inhibition of htt ameliorates symptoms in depressed patients. |
2008-03-10 |
2023-08-12 |
mouse |
| . Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genetics in medicine : official journal of the American College of Medical Genetics. vol 9. issue 12. 2008-03-07. PMID:18091431. |
recommendations from the egapp working group: testing for cytochrome p450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. |
2008-03-07 |
2023-08-12 |
Not clear |
| Mugdha Thakur, Iris Grossman, Douglas C McCrory, Lori A Orlando, David C Steffens, Kathryn E Cline, Rebecca N Gray, Jennifer Farmer, Georgette DeJesus, Cara O'Brien, Gregory Samsa, David B Goldstein, David B Matcha. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors. Genetics in medicine : official journal of the American College of Medical Genetics. vol 9. issue 12. 2008-03-07. PMID:18091432. |
review of evidence for genetic testing for cyp450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors. |
2008-03-07 |
2023-08-12 |
Not clear |
| Mugdha Thakur, Iris Grossman, Douglas C McCrory, Lori A Orlando, David C Steffens, Kathryn E Cline, Rebecca N Gray, Jennifer Farmer, Georgette DeJesus, Cara O'Brien, Gregory Samsa, David B Goldstein, David B Matcha. Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors. Genetics in medicine : official journal of the American College of Medical Genetics. vol 9. issue 12. 2008-03-07. PMID:18091432. |
cytochrome p450 (cyp450) enzymes metabolize selective serotonin reuptake inhibitor (ssri) drugs used in treatment of depression. |
2008-03-07 |
2023-08-12 |
Not clear |
| David Brent, Graham Emslie, Greg Clarke, Karen Dineen Wagner, Joan Rosenbaum Asarnow, Marty Keller, Benedetto Vitiello, Louise Ritz, Satish Iyengar, Kaleab Abebe, Boris Birmaher, Neal Ryan, Betsy Kennard, Carroll Hughes, Lynn DeBar, James McCracken, Michael Strober, Robert Suddath, Anthony Spirito, Henrietta Leonard, Nadine Melhem, Giovanna Porta, Matthew Onorato, Jamie Zelazn. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. vol 299. issue 8. 2008-03-07. PMID:18314433. |
only about 60% of adolescents with depression will show an adequate clinical response to an initial treatment trial with a selective serotonin reuptake inhibitor (ssri). |
2008-03-07 |
2023-08-12 |
Not clear |
| Charles B Nemeroff, Richard Entsuah, Isma Benattia, Mark Demitrack, Diane M Sloan, Michael E Thas. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological psychiatry. vol 63. issue 4. 2008-02-29. PMID:17888885. |
to compare venlafaxine and selective serotonin reuptake inhibitors (ssris; fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram) in the treatment of depression. |
2008-02-29 |
2023-08-12 |
Not clear |
| William Bernet, Cindy L Vnencak-Jones, Nita Farahany, Stephen A Montgomer. Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials. Journal of forensic sciences. vol 52. issue 6. 2008-02-28. PMID:17944904. |
also, individuals who were born with particular alleles of the serotonin transporter gene and also experienced multiple stressful life events were more likely to manifest serious depression and suicidality. |
2008-02-28 |
2023-08-12 |
human |
| Svetlana Semenova, Mark A Geyer, J Gregor Sutcliffe, Athina Markou, Peter B Hedlun. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biological psychiatry. vol 63. issue 1. 2008-02-27. PMID:17531208. |
studies have implicated the serotonin (5-ht)(7) receptor in physiological and pathophysiological phenomena, including thermoregulation, central control of micturition and locomotion, regulation of circadian rhythm, sleep, and depression. |
2008-02-27 |
2023-08-12 |
Not clear |
| Michael E Thase, Yili Lu Pritchett, Melissa J Ossanna, Ralph W Swindle, Jimmy Xu, Michael J Detk. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. Journal of clinical psychopharmacology. vol 27. issue 6. 2008-02-26. PMID:18004135. |
thus, whereas duloxetine and the 2 ssris were comparably efficacious overall, therapy with the serotonin and norepinephrine reuptake inhibitor resulted in a significantly higher remission rate among patients with moderate-to-severe depression. |
2008-02-26 |
2023-08-12 |
Not clear |
| John P O'Reardon, Mohit P Chopra, Alexandra Bergan, Robert Gallop, Robert J DeRubeis, Paul Crits-Christop. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biological psychiatry. vol 55. issue 9. 2008-02-25. PMID:15110741. |
response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. |
2008-02-25 |
2023-08-12 |
Not clear |
| Ryohei Matsumoto, Tetsuya Suhar. [Pathophysiology and treatment of depression: a review of PET imaging of serotonin transporter. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. vol 130. issue 6. 2008-02-21. PMID:18079596. |
[pathophysiology and treatment of depression: a review of pet imaging of serotonin transporter. |
2008-02-21 |
2023-08-12 |
Not clear |
| Wayne C Drevets, Michael E Thase, Eydie L Moses-Kolko, Julie Price, Ellen Frank, David J Kupfer, Chester Mathi. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear medicine and biology. vol 34. issue 7. 2008-02-20. PMID:17921037. |
we have previously assessed 5-ht1ar binding potential (bp) in depression using positron emission tomography (pet) and [carbonyl-(11)c]way-100635, and we have demonstrated reduced 5-ht1ar bp in the mesiotemporal cortex (mtc) and raphe in depressives with primary recurrent familial mood disorders (n=12) versus controls (n=8) [drevets wc, frank e, price jc, kupfer dj, holt d, greer pj, huang y, gautier c, mathis c. pet imaging of serotonin 1a receptor binding in depression. |
2008-02-20 |
2023-08-12 |
human |